Prairie Research And Education Cooperative
- Assets
- $4.4m
- Revenue
- $4.2m
- Investments
- $0.0
- Employees
- 25
- Location
- Springfield, IL
- Founding
- 04/1986
- Data as of
- 06/2022
- EIN
- 37-1157915
Organization Overview
Prairie Research And Education Cooperative is located in Springfield, IL. The organization was established in 1986. According to its NTEE Classification (H43) the organization is classified as: Heart & Circulatory System Diseases & Disorders Research, under the broad grouping of Medical Research and related organizations. As of 06/2022, Prairie Research And Education Cooperative employed 25 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Prairie Research And Education Cooperative is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Prairie Research And Education Cooperative generated $4.2m in total revenue. This represents relatively stable growth, over the past 5 years the organization has increased revenue by an average of 3.8% each year. All expenses for the organization totaled $3.9m during the year ending 06/2022. While expenses have increased by 4.2% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE PURPOSE OF THE ORGANIZATION IS TO ENGAGE IN ACTIVE CONTINUOUS MEDICAL RESEARCH TO FURTHER THE UNDERSTANDING OF APPLICATIONS OF NEW MODES OF THERAPY FOR CARDIOVASCULAR DISEASE, DIABETES AND NEUROLOGICAL DISORDERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
-PARTICIPATE IN PHASE I-IV CLINICAL TRIALS AS AN ENROLLING SITE IN A WIDE RANGE OF THERAPEUTIC AREAS WITH A FOCUS ON CARDIOVASCULAR, DIABETES, AND NEUROLOGY RESEARCH. TRIALS ARE SPONSORED AND FUNDED BY DEVICE AND PHARMACEUTICAL COMPANIES. PARTICIPATED IN APPROXIMATELY 48 CARDIOVASCULAR TRIALS, 13 DIABETES TRIALS, AND 8 NEUROLOGY TRIALS IN FY 2022. -CONDUCT CEC/DSMB MANAGEMENT FOR MEDICAL DEVICE SPONSORS. PROVIDE INDIVIDUALS WITH EXPERTISE TO ADVISE THE SPONSOR ON THE CONTINUING SAFETY OF TRIAL SUBJECTS. PROVIDE OVERSIGHT OF TRIAL DATA TO DETERMINE THAT SPONSORS ARE COMPLIANT WITH CONDUCTING TRIALS THAT ARE ETHICAL, SAFE FOR SUBJECTS, AND PRODUCE GOOD, RELIABLE DATA. PROVIDED CEC/DSMB MANAGEMENT FOR APPROXIMATELY 8 CLINICAL TRIALS IN FY 2022. -PROVIDE ANALYSIS OF ANGIOGRAPHIC IMAGES FOR CLINICAL RESEARCH TRIALS SPONSORED BY DEVICE OR PHARMACEUTICAL COMPANIES. PROVIDED ANGIOGRAPHIC ANALYSIS IN APPROXIMATELY 7 CLINICAL TRIALS IN FY 2022.
CONTINUING EDUCATION: PROVIDE ALL FORMS OF CONTINUING EDUCATION FOR THE ENTIRE HSHS SYSTEM. THE PROGRAM STRIVES TO PROVIDE EDUCATIONAL ACTIVITIES THAT ARE BASED ON IDENTIFIED GAPS THROUGH A FORMAL NEEDS ASSESSMENT INVOLVING THE EDUCATIONAL FACILITATORS, PROGRAM PLANNERS, AND CONTENT REVIEWERS. THE SCOPE OF THE PROGRAMS INCLUDE, BUT ARE NOT LIMITED TO: CARDIAC, VASCULAR, AND GENERAL MEDICAL CARE, INCLUDING PREVENTION, DIAGNOSIS, TREATMENT, REHABILITATION, QUALITY IMPROVEMENT, AND COST EFFECTIVENESS. THERE WERE APPROXIMATELY 138 CME AND 54 CNE EVENTS CONDUCTED IN FY 2022.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Name Not Listed 2021 Secretary | OfficerTrustee | 1 | $0 |
Name Not Listed Treasurer | OfficerTrustee | 1 | $0 |
Name Not Listed Chairman | OfficerTrustee | 1 | $0 |
Name Not Listed 2021 President & CEO / Physician | OfficerTrustee | 1 | $0 |
Name Not Listed Director | Trustee | 1 | $0 |
Name Not Listed Director / Physician | Trustee | 40 | $586,492 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $125,000 |
| Government grants | $27,715 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $152,715 |
| Total Program Service Revenue | $3,996,060 |
| Investment income | -$283 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $51,174 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $4,199,666 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $861,296 |
| Compensation of current officers, directors, key employees. | $656,495 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,798,447 |
| Pension plan accruals and contributions | $118,159 |
| Other employee benefits | $277,614 |
| Payroll taxes | $132,621 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $6,522 |
| Fees for services: Other | $295,068 |
| Advertising and promotion | $0 |
| Office expenses | $15,562 |
| Information technology | $17,775 |
| Royalties | $0 |
| Occupancy | $238,978 |
| Travel | $25,901 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $785 |
| Interest | $100 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $15,400 |
| Insurance | $42,399 |
| All other expenses | $10,000 |
| Total functional expenses | $3,917,434 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,594,002 |
| Savings and temporary cash investments | $853,701 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $572,394 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $60,427 |
| Net Land, buildings, and equipment | $25,360 |
| Investments—publicly traded securities | $1,223,320 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $88,406 |
| Total assets | $4,417,610 |
| Accounts payable and accrued expenses | $237,404 |
| Grants payable | $0 |
| Deferred revenue | $73,439 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $104,775 |
| Total liabilities | $415,618 |
| Net assets without donor restrictions | $4,001,992 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $4,417,610 |